Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke

Stroke. 2017 Jun;48(6):1695-1699. doi: 10.1161/STROKEAHA.116.015956. Epub 2017 Apr 20.

Abstract

Background and purpose: Hemorrhagic transformation is the main complication of revascularization therapies after stroke. Toll-like receptor 4 (TLR4) is implicated in cerebral damage and inflammation in stroke. This study was designed to determine the role of TLR4 in hemorrhagic transformation development after tissue plasminogen activator (tPA) administration.

Methods: Mice expressing (TLR4+/+) or lacking functional TLR4 (TLR4-/-) were subjected to middle cerebral artery occlusion using an in situ thromboembolic model by thrombin injection into the middle cerebral artery, and tPA (10 mg/kg) was administered 20 minutes or 3 hours after ischemia. Infarct size, hemorrhages, IgG extravasation, matrix metalloproteinase 9 expression, and neutrophil infiltration were assessed 24 hours after ischemia.

Results: In TLR4+/+, early reperfusion (tPA at 20 minutes) resulted infarct volume, whereas late recanalization (tPA at 3 hours) did not modify lesion size and increased the rate of the most severe hemorrhages. In TLR4-/- mice, both early and late reperfusion did not modify lesion size. Importantly, late tPA administration did not result in worse hemorrhages and in an increased bleeding area as occurred in TLR4+/+ group. In TLR4-/- animals, late reperfusion produced a lesser increase in matrix metalloproteinase 9 expression when compared with TLR4+/+ animals.

Conclusions: Our results demonstrate TLR4 involvement in hemorrhagic transformation induced by delayed tPA administration, very likely by increasing matrix metalloproteinase 9 expression.

Keywords: blood–brain barrier; hemorrhage; inflammation; middle cerebral artery; stroke.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / etiology
  • Brain Ischemia / metabolism
  • Cerebral Hemorrhage / chemically induced
  • Cerebral Hemorrhage / metabolism*
  • Cerebral Infarction / drug therapy
  • Cerebral Infarction / metabolism
  • Disease Models, Animal
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / pharmacology*
  • Infarction, Middle Cerebral Artery / complications
  • Intracranial Embolism / complications
  • Intracranial Thrombosis / complications
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Stroke / drug therapy*
  • Stroke / etiology
  • Stroke / metabolism
  • Time Factors
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / pharmacology*
  • Toll-Like Receptor 4 / metabolism*

Substances

  • Fibrinolytic Agents
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • Tissue Plasminogen Activator